What Protein Biomarkers Can Detect Immunotherapy-Related Adverse Events?
Modern cancer treatments like immune checkpoint inhibitors and CAR-T cell therapies help the immune system recognize and destroy tumor cells. However, when immune activity ramps up too aggressively, it can inflame healthy organs and trigger immunotherapy-related adverse events (irAEs). Identifying these reactions early—before severe clinical symptoms force doctors to pause...
0 Комментарии 0 Поделились 73 Просмотры 0 предпросмотр
Спонсоры
Спонсоры